...
首页> 外文期刊>Saudi Pharmaceutical Journal >Nanotechnology as a tool to overcome the bariatric surgery malabsorption
【24h】

Nanotechnology as a tool to overcome the bariatric surgery malabsorption

机译:纳米技术作为克服畜分手术中的工具

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Obesity is a metabolic disease that affects all ages; it is considered life-threatening condition as it leads to fatal complications such as; cardiovascular diseases and diabetes. The therapeutic options include; life-style modifications, pharmacotherapy intervention, and surgical intervention. Bariatric surgery (BS) is considered as the most effective option among the others for its rapid weight loss, maintaining the lost mass, and improving the quality of life of the patients. Nevertheless, BS leads to severe changes in the bioavailability of medications, especially for chronic diseases, which may reach to limit where the patient's life endangers. Recently, pharmaceutical formulations had developed several methods to improve the drug bioavailability of drugs though the implying of nanotechnology. Nonotechnology is responsible for reducing the size of the drugs to the nano range (1000?nm), which increase the drug surface area, dissolution, absorption, and, most importantly, the bioavailability of these drugs. It is believed that BS malabsorption and drugs bioavailability problems can be solved using nanotechnology for its advantages in overcoming BS complications.
机译:肥胖是一种影响所有年龄段的代谢疾病;它被认为是威胁危及的病症,因为它导致致命并发症如;心血管疾病和糖尿病。治疗选项包括;生活方式修饰,药物治疗干预和手术干预。畜牧手术(BS)被认为是其其他方面最有效的选择,以实现其快速减肥,保持损失,提高患者的生活质量。然而,BS导致药物的生物利用度严重变化,特别是对于慢性疾病,这可能达到患者寿命危害的地方。最近,药物制剂制定了几种方法,以提高药物的药物生物利用性,尽管纳米技术暗示。非技术负责将药物的大小降低到纳米范围(<1000〜Nm),这增加了药物表面积,溶解,吸收,以及最重要的是这些药物的生物利用度。据信,BS不吸收和药物的生物利用度问题可以使用纳米技术解决其优点克服BS并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号